Relationship between Apparent Diffusion Coefficient Distribution and Cancer Grade in Prostate Cancer and Benign Prostatic Hyperplasia

被引:8
|
作者
Saito, Shigeyoshi [1 ,2 ]
Koyama, Yoshihiro [3 ]
Ueda, Junpei [1 ]
Hashido, Takashi [3 ]
机构
[1] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Med Phys & Engn, Osaka 5650871, Japan
[2] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Adv Med Technol, Osaka 5650871, Japan
[3] Osaka Univ Hosp, Dept Med Technol, Div Radiol, Osaka 5648565, Japan
基金
日本学术振兴会;
关键词
histogram-derived ADC parameters; stromal hyperplasia; glandular hyperplasia; prostate cancer; benign prostate hyperplasia; CONTRAST-ENHANCED MRI; LOCAL TREATMENT; GLEASON SCORE; NORMAL TISSUE; GUIDELINES; DIAGNOSIS; DIFFERENTIATION; CELLULARITY; UPDATE; BIOPSY;
D O I
10.3390/diagnostics12020525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this paper was to assess the associations between prostate cancer aggressiveness and histogram-derived apparent diffusion coefficient (ADC) parameters and determine which ADC parameters may help distinguish among stromal hyperplasia (SH), glandular hyperplasia (GH), and low-grade, intermediate-grade, and high-grade prostate cancers. The mean, median, minimum, maximum, and 10th and 25th percentile ADC values were determined from the ADC histogram and compared among two benign prostate hyperplasia (BPH) groups and three Gleason score (GS) groups. Seventy lesions were identified in 58 patients who had undergone proctectomy. Thirty-nine lesions were prostate cancers (GS 6 = 7 lesions, GS 7 = 19 lesions, GS 8 = 11 lesions, GS 9 = 2 lesions), and thirty-one lesions were BPH (SH = 15 lesions, GH = 16 lesions). There were statistically significant differences in 10th percentile and 25th percentile ADC values when comparing GS 6 to GS 7 (p < 0.05). The 10th percentile ADC values yielded the highest area under the curve (AUC). Tenth and 25th percentile ADCs can be used to more accurately differentiate lesions with GS 6 from those with GS 7 than other ADC parameters. Our data indicate that the major challenge with ADC mapping is to differentiate between SH and GS 6, and SH and GS 7.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
    De Nunzio, Cosimo
    Kramer, Gero
    Marberger, Michael
    Montironi, Rodolfo
    Nelson, William
    Schroder, Fritz
    Sciarra, Alessandro
    Tubaro, Andrea
    EUROPEAN UROLOGY, 2011, 60 (01) : 106 - 117
  • [2] Role of Apparent Diffusion Coefficient Value and Apparent Diffusion Coefficient Ratio as Prognostic Factors for Prostate Cancer Aggressiveness
    Buss, Arvids
    Radzina, Maija
    Liepa, Mara
    Birkenfelds, Edgars
    Saule, Laura
    Miculis, Karlis
    Mikelsone, Madara
    Vjaters, Egils
    DIAGNOSTICS, 2024, 14 (21)
  • [3] Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature Review
    Alcaraz, Antonio
    Hammerer, Peter
    Tubaro, Andrea
    Schroder, Fritz H.
    Castro, Ramiro
    EUROPEAN UROLOGY, 2009, 55 (04) : 864 - 875
  • [4] The impact of benign prostatic hyperplasia on bladder volume in radiotherapy of prostate cancer
    Jang, H.
    Baek, J. G.
    Kwon, S. Y.
    Lee, K. S.
    Oh, Y. T.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2019, 17 (03): : 401 - 406
  • [5] Assessment of Aggressiveness of Prostate Cancer: Correlation of Apparent Diffusion Coefficient With Histologic Grade After Radical Prostatectomy
    Verma, Sadhna
    Rajesh, Arumugam
    Morales, Humberto
    Lemen, Lisa
    Bills, Gordon
    Delworth, Mark
    Gaitonde, Krish
    Ying, Jun
    Samartunga, Ranasinghe
    Lamba, Michael
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 196 (02) : 374 - 381
  • [6] Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review
    McNally, Christopher J.
    Ruddock, Mark W.
    Moore, Tara
    McKenna, Declan J.
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5225 - 5241
  • [7] Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer
    Gupta, Rajan T.
    Kauffman, Christopher R.
    Garcia-Reyes, Kirema
    Palmeri, Mark L.
    Madden, John F.
    Polascik, Thomas J.
    Rosenkrantz, Andrew B.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 205 (02) : 331 - 336
  • [8] Osteopontin expression in prostate cancer and benign prostatic hyperplasia
    Tozawa, K
    Yamada, Y
    Kawai, N
    Okamura, T
    Ueda, K
    Kohri, K
    UROLOGIA INTERNATIONALIS, 1999, 62 (03) : 155 - 158
  • [9] Decision Aids for Benign Prostatic Hyperplasia and Prostate Cancer
    Arterburn, David
    Wellman, Robert
    Westbrook, Emily O.
    Ross, Tyler R.
    McCulloch, David
    Handley, Matt
    Lowe, Marc
    Cable, Chris
    Zeliadt, Steven B.
    Hoffman, Richard M.
    AMERICAN JOURNAL OF MANAGED CARE, 2015, 21 (02): : E130 - +
  • [10] Oxidative Stress in Benign Prostatic Hyperplasia and Prostate Cancer
    Pace, Gianna
    Di Massimo, Caterina
    De Amicis, Daniela
    Corbacelli, Carlo
    Di Renzo, Laura
    Vicentini, Carlo
    Miano, Lucio
    Ciancarelli, Maria Giuliana Tozzi
    UROLOGIA INTERNATIONALIS, 2010, 85 (03) : 328 - 333